Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Buttermore, Elizabeth D  [Clear All Filters]
Journal Article
Afshar-Saber W, Teaney NA, Winden KD, Jumo H, Shi X, McGinty G, Hubbs J, Chen C, Latzer ITokatly, Gasparoli F, et al. ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations. Neurobiol Dis. 2023:106386.
Shum C, Han SYeon, Thiruvahindrapuram B, Wang Z, de Rijke J, Zhang B, Sundberg M, Chen C, Buttermore ED, Makhortova N, et al. Combining Off-flow, a Nextflow-coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs. Comput Struct Biotechnol J. 2024;23:638-647.
Chen P-F, Chen T, Forman TE, Swanson AC, O'Kelly B, Dwyer SA, Buttermore ED, Kleiman R, Carrington SJs, Lavery DJ, et al. Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD). Stem Cell Res. 2021;53:102276.
Teinert J, Behne R, D'Amore A, Wimmer M, Dwyer S, Chen T, Buttermore ED, Chen IPin-Fang, Sahin M, Ebrahimi-Fakhari D. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47). Stem Cell Res. 2019;40:101575.
Saffari A, Brechmann B, Böger C, Saber WAfshar, Jumo H, Whye D, Wood D, Wahlster L, Alecu JE, Ziegler M, et al. High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia. Nat Commun. 2024;15(1):584.
Wainger BJ, Buttermore ED, Oliveira JT, Mellin C, Lee S, Saber WAfshar, Wang AJ, Ichida JK, Chiu IM, Barrett L, et al. Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts. Nat Neurosci. 2014.